Related Experiment Video
Updated: Dec 13, 2025

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Subcutaneous Extended-Release Buprenorphine Use in Pregnancy
Craig V Towers1, Heather Deisher1
1Obstetrics and Gynecology, Maternal-Fetal Medicine, High Risk Obstetrical Consultants, Knoxville, Tennessee 37920, USA.
Extended-release subcutaneous buprenorphine (Sublocade) may be a safe option for pregnant women with opioid use disorder (OUD). Two cases showed no adverse outcomes for mothers or neonates, suggesting potential for future use.
Area of Science:
- Obstetrics and Gynecology
- Addiction Medicine
- Pharmacology
Background:
- Opioid use disorder (OUD) in pregnancy necessitates medication-assisted treatment.
- Sublingual buprenorphine is a standard treatment, while subcutaneous extended-release buprenorphine (Sublocade) offers an alternative monthly injection.
- No prior studies documented Sublocade use during pregnancy.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Drugs for Treatment of Constipation-Predominant IBS
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Parenteral Anesthetics: Overview

